Abivax SA American Depositary Shares (ABVX) is a publicly traded Healthcare sector company. As of May 21, 2026, ABVX trades at $118.66 with a market cap of $9.00B and a P/E ratio of 0.00. ABVX moved +5.32% today. Year to date, ABVX is -2.70%; over the trailing twelve months it is +1967.24%. Its 52-week range spans $4.77 to $148.83. Analyst consensus is strong buy with an average price target of $152.25. Rallies surfaces ABVX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ABVX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $118.66 |
| Market Cap | $9.00B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $148.83 |
| 52-Week Low | $4.77 |
| Volume | 10.70K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
8 analysts cover ABVX: 0 strong buy, 7 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $152.25.